Skip to main content

Tbo-Filgrastim Dosage

Medically reviewed by Drugs.com. Last updated on Jun 6, 2024.

Applies to the following strengths: 300 mcg/0.5 mL; 480 mcg/0.8 mL; 300 mcg/mL; 480 mcg/1.6 mL

Usual Adult Dose for Neutropenia Associated with Chemotherapy

5 mcg/kg via subcutaneous injection once a day

passed and the neutrophil count has recovered to the normal range.

Comments:

Use: To reduce the duration of severe neutropenia in patients receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia

Usual Pediatric Dose for Neutropenia Associated with Chemotherapy

1 month and older: 5 mcg/kg via subcutaneous injection once a day

passed and the neutrophil count has recovered to the normal range.

Comments:

Use: To reduce the duration of severe neutropenia in patients receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia

Renal Dose Adjustments

Data not available

Glomerulonephritis:

Liver Dose Adjustments

Data not available

Dose Adjustments

Sickle cell crisis occurrence: Discontinue treatment.

Serious allergic reactions: Permanently discontinue treatment.

Suspected/confirmed splenic rupture, or aortitis, or acute respiratory distress syndrome (ARDS): Discontinue treatment.

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 1 month.

Consult WARNINGS section for dosing related precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

General:

Monitoring:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.